Recent short interest data for the 8/29/2014 settlement date shows a decrease in short interest for shares of Gilead Sciences Inc. (GILD). As of August 29, the short interest for the biopharmaceutical company totaled 75,491,965 shares, as compared to 90,068,658 shares since August 15, a decline of -16.18%. Average daily volume [AVM] for the same period rose by 2.76M to 14,328,256 shares from 11,565,205 shares. It is worth mentioning that ticker’s short interest has declined by more than 22.75M shares, or 23.15%, from the 5/15/2014 settlement date.
Based on the latest AVM, the days-to-cover ratio — a metric that includes both the total shares short and the average daily volume of shares traded — is currently 5.26 days. Days-to-cover for GILD decreased to 5.26 for the August 29 settlement date, as compared to 7.78 days at the August 15 report.
Gilead Sciences Inc. has a beta of 0.95 and a short float of 5.03%. In the past 52 weeks, shares of the Foster City, California-based company have traded between a low of $58.81 and a high of $110.64 and are now at $108.22. Shares are up 77.06% year-over-year and down 44.10% year-to-date.
The chart below shows where the equity has traded over the last year, with the 50-day and 200-day moving averages included.
Recent short interest data for the 8/29/2014 settlement date shows a decrease in short interest for shares of Regeneron Pharmaceuticals, Inc. (REGN). As of August 29, the short interest for the biotech firm totaled 3,504,174 shares, as compared to 3,845,797 shares since August 15, a decline of -8.88%. Average daily volume [AVM] for the same period fell by 379,132 to 465,402 shares from 844,534 shares. It is worth mentioning that ticker’s short interest has declined by more than 1.14M shares, or 24.54%, from the 5/30/2014 settlement date.
Based on the latest AVM, the days-to-cover ratio — a metric that includes both the total shares short and the average daily volume of shares traded — is currently 7.52 days. Days-to-cover for REGN increased to 7.52 for the August 29 settlement date, as compared to 4.55 days at the August 15 report.
Regeneron Pharmaceuticals has a beta of 0.65 and a short float of 4.75%. In the past 52 weeks, shares of the Tarrytown, New York-based company have traded between a low of $257.69 and a high of $369.31 and are now at $354.32. Shares are up 32.42% year-over-year and down 28.73% year-to-date.
The chart below shows where the equity has traded over the last year, with the 50-day and 200-day moving averages included.
Recent short interest data for the 8/29/2014 settlement date shows an increase in short interest for shares of GlaxoSmithKline plc (GSK). As of August 29, the short interest for the manufacturer of pharmaceutical products totaled 12,035,233 shares, as compared to 8,837,816 shares since August 15, an increase of 36.18%. Average daily volume [AVM] for the same period fell by 1M to 3,106,243 shares from 4,105,274 shares. It is worth mentioning that ticker’s short interest has jumped by more than 7.30M shares, or 154.54%, from the 1/15/2014 settlement date.
Based on the latest AVM, the days-to-cover ratio — a metric that includes both the total shares short and the average daily volume of shares traded — is currently 3.87 days. Days-to-cover for GSK increased to 3.87 for the August 29 settlement date, as compared to 2.15 days at the August 15 report.
GlaxoSmithKline plc has a beta of 0.74 and a short float of 0.51%. In the past 52 weeks, shares of the Brentford, UK-based company have traded between a low of $46.01 and a high of $56.73 and are now at $47.28. Shares are down 8.50% year-over-year and 11.44% year-to-date.
The chart below shows where the equity has traded over the last year, with the 50-day and 200-day moving averages included.
Recent short interest data for the 8/29/2014 settlement date shows an increase in short interest for shares of Mobileye N.V. (MBLY). As of August 29, the short interest for the developer of software camera-based advanced driver assistance systems totaled 1,526,450 shares, as compared to 1,096,708 shares since August 15, an increase of 39.19%. Average daily volume [AVM] for the same period fell by 2.63M to 3,641,216 shares from 6,278,990 shares.
Based on the latest AVM, the days-to-cover ratio — a metric that includes both the total shares short and the average daily volume of shares traded — is currently 1.00 day. Days-to-cover for MBLY remained to 1.00 for the August 29 settlement date.
In the past 2 months, shares of the Jerusalem, Israel-based company have traded between a low of $31.11 and a high of $58.61 and are now at $55.48.
The chart below shows where the equity has traded over the last year, with the 50-day and 200-day moving averages included.
Recent short interest data for the 8/29/2014 settlement date shows a decrease in short interest for shares of The WhiteWave Foods Company (WWAV). As of August 29, the short interest for the foods and beverages company totaled 2,126,666 shares, as compared to 2,222,162 shares since August 15, a decline of -4.30 %. Average daily volume [AVM] for the same period fell by 812,000 to 1,436,051 shares from 2,248,718 shares.
Based on the latest AVM, the days-to-cover ratio — a metric that includes both the total shares short and the average daily volume of shares traded — is currently 1.48 days. Days-to-cover for WWAV increased to 1.48 for the August 29 settlement date, as compared to 1.00 days at the August 15 report.
The WhiteWave Foods Company has a beta of 1.48 and a short float of 1.24%. In the past 52 weeks, shares of the Denver, Colorado-based company have traded between a low of $18.28 and a high of $37.29 and are now at $37.06. Shares are up 87.55% year-over-year and 61.48% year-to-date.
The chart below shows where the equity has traded over the last year, with the 50-day and 200-day moving averages included.
Leave a Reply